Outpatient Intensive Chemotherapy for Small Cell Lung Cancer: Five Years Experience of Modified ‘ICE’ Ifosfamide Carboplatin and Etoposide
- 31 October 2002
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Oncology
- Vol. 14 (5), 367-371
- https://doi.org/10.1053/clon.2002.0097
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Guideline DocumentClinical Oncology, 1999
- Modified ice study: A phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancerLung Cancer, 1998
- Small Cell Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1997
- Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiationEuropean Journal of Cancer, 1994
- Ifosfamide/carboplatin/etoposide (ICE) regimen in small cell lung cancerLung Cancer, 1993
- Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisEuropean Journal of Cancer and Clinical Oncology, 1990
- Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer: Report to the medical research council by its lung cancer working partyRespiratory Medicine, 1989
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987
- Reporting results of cancer treatmentCancer, 1981
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976